Scynexis (SCYX) Shares Outstanding (2013 - 2026)
Scynexis (SCYX) posted Shares Outstanding (Entity) of $5.4 million for Q4 2025, up 3.78% on a QoQ basis from $5.2 million in Q3 2025, and down 10.25% year-over-year from $6.1 million in Q4 2024.
Scynexis (SCYX) Shares Outstanding (2013 - 2026) Analysis & Trends
Scynexis' Shares Outstanding (Entity) history runs 12 years deep, the most recent figure standing at $5.4 million for Q4 2025.
- Quarterly Shares Outstanding (Entity) fell 10.25% year-over-year to $5.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.4 million (down 10.25% YoY) and the FY2025 annual result came in at $5.4 million, down 10.25% from the prior year.
- Shares Outstanding (Entity) was $5.4 million for Q4 2025 at Scynexis, up from $5.2 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $6.2 million in Q2 2025 and bottomed at $2.9 million in Q2 2021.
- A 5-year average of $5.2 million and a median of $6.0 million in 2022 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) soared 167.77% — and 2025, when it retreated 13.7%.
- Scynexis' Shares Outstanding (Entity) stood at $3.6 million in 2021, then soared by 48.45% to $5.3 million in 2022, then rose by 12.29% to $6.0 million in 2023, then increased by 1.38% to $6.1 million in 2024, then slipped by 10.25% to $5.4 million in 2025.
- Business Quant data shows SCYX's Shares Outstanding (Entity) at $5.4 million in Q4 2025, $5.2 million in Q3 2025, and $6.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 497.70 Mn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | 6.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.37 Mn |
| Dec 31, 2025 | 6.24 Mn |
| Sep 30, 2025 | 6.24 Mn |
| Jun 30, 2025 | 6.22 Mn |
| Mar 31, 2025 | 6.18 Mn |
| Dec 31, 2024 | 6.06 Mn |
| Sep 30, 2024 | 6.08 Mn |
| Jun 30, 2024 | 6.06 Mn |
| Mar 31, 2024 | 6.03 Mn |
| Dec 31, 2023 | 5.98 Mn |
| Sep 30, 2023 | 5.99 Mn |
| Jun 30, 2023 | 5.98 Mn |
| Mar 31, 2023 | 5.97 Mn |
| Dec 31, 2022 | 5.33 Mn |
| Sep 30, 2022 | 5.94 Mn |
| Jun 30, 2022 | 5.41 Mn |
| Mar 31, 2022 | 4.01 Mn |
| Dec 31, 2021 | 3.30 Mn |
| Sep 30, 2021 | 3.33 Mn |
| Jun 30, 2021 | 3.25 Mn |